Skip to content

Single Cell Discoveries

Single Cell Discoveries is a science-led contract research organization (CRO) specializing in single-cell sequencing, spatial transcriptomics, and multi-omics services for pharmaceutical, biotechnology, and academic clients.

Last updated September 29, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Single Cell Discoveries (SCD) is a Netherlands-based contract research organization (CRO) that provides single-cell sequencing, spatial transcriptomics, bulk RNA sequencing, and related multi-omics services. The company positions itself as a specialist precision biology CRO supporting pharmaceutical, biotechnology, and academic organizations from discovery through validation and clinical development. Its service portfolio includes single-cell sequencing (including the proprietary SORT-seq technology, for which it is the exclusive provider), 10x Genomics sequencing, VASA-seq, Discovery-seq, bulk RNA sequencing, spatial transcriptomics, qPCR, dPCR, proteomics, and regulatory-ready bioanalysis. SCD operates laboratories in the Netherlands and Sweden, with its main laboratory located in Utrecht. The company emphasizes direct collaboration between customers and the scientists who design, execute, and interpret studies, aiming to provide customized solutions, rapid turnaround times, and high-quality data. It serves research areas such as oncology, immunology, developmental biology, and neuroscience, and applications including biodistribution, drug development, cell type identification, and immune profiling. As a private company, SCD does not disclose detailed financial information publicly. Its team consists largely of PhD scientists, and it has been recognized as a 10x Genomics Certified Service Provider. The company continues to expand its service offerings and global client base.

History

Single Cell Discoveries was founded as a spin-off from the Hubrecht Institute in the Netherlands, with a focus on single-cell science. The company began as a bold idea and grew into an industry-leading single-cell laboratory. It developed and exclusively offers SORT-seq, a plate-based single-cell transcriptomics technology based on FACS sorting and 384-well plates, invented by its founders. Over time, SCD expanded its services to include bulk RNA sequencing, spatial transcriptomics, multi-omics, qPCR, dPCR, proteomics, and regulatory-ready bioanalysis. It established laboratories in the Netherlands and Sweden, with its main laboratory in Utrecht. The company became a 10x Genomics Certified Service Provider and continues to serve pharmaceutical, biotechnology, and academic clients globally.

  • Founded as a spin-off from the Hubrecht Institute

  • Developed SORT-seq technology and became its exclusive provider

  • Became a 10x Genomics Certified Service Provider

  • Opened brand-new laboratory in Utrecht, Netherlands

Products and positioning

Specialist precision biology CRO offering end-to-end transcriptomics and multi-omics services with direct scientist collaboration.

  • SORT-seq

    Plate-based single-cell transcriptomics technology based on FACS sorting and 384-well plates, exclusively offered by Single Cell Discoveries.

  • 10x Genomics Sequencing Service

    Certified service provider for 10x Genomics single-cell and multiome sequencing.

  • Discovery-seq

    Enhanced Drug-seq alternative with improved sensitivity and robustness, optimized for large-scale compound screening and mode-of-action studies.

  • VASA-seq

    Single-cell sequencing service.

  • Bulk RNA sequencing

    Transcriptomics service for bulk samples.

  • Spatial transcriptomics

    Service for spatial gene expression analysis.

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/single-cell-discoveries-netherlands · Editorial policy · How profiles are compiled